Details of the Competitor
General Information of Competitor
The Competitor Interaction Atlas
Probe(s) Related This Competitor
ABPP Probe
| Probe Name | Structure | Concentration | Cell-system | Ref | |
|---|---|---|---|---|---|
|
SAHA-CA-4PAP Probe Info |
![]() |
3 uM | Human chronic myeloid leukemia cell lysate (K562) | [1] | |
PAL-AfBPP Probe
| Probe Name | Structure | Concentration | Cell-system | Ref | |
|---|---|---|---|---|---|
|
SAHA-CA-8PAP Probe Info |
![]() |
1 uM | Human chronic myeloid leukemia cell lysate (K562) | [1] | |
|
SAHA-CA-3PAP Probe Info |
![]() |
1 uM | Human chronic myeloid leukemia cell lysate (K562) | [1] | |
Target(s) List of this Competitor
|
34 Enzyme Competed by This
Competitor
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
9 Transporter and channel Competed by This
Competitor
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
4 Transcription factor Competed by This
Competitor
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
36 Other Competed by This
Competitor
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Information of The Labelling Profiles of This Competitor
SAHA-CA-4PAP
Quantification: Probe vs (Probe+Competitor)
|
Experiment 1 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Chronic myeloid leukemia [ICD-11:2A20] | ||||
| Human chronic myeloid leukemia cell lysate (K562) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 2 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Chronic myeloid leukemia [ICD-11:2A20] | ||||
| Human chronic myeloid leukemia cell lysate (K562) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 3 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Chronic myeloid leukemia [ICD-11:2A20] | ||||
| Human chronic myeloid leukemia cell lysate (K562) | ||||
| Interaction Atlas ID |
|
|||
SAHA-CA-3PAP
Quantification: Probe vs (Probe+Competitor)
|
Experiment 1 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Chronic myeloid leukemia [ICD-11:2A20] | ||||
| Human chronic myeloid leukemia cell lysate (K562) | ||||
| Interaction Atlas ID |
|
|||
SAHA-CA-8PAP
Quantification: Probe vs (Probe+Competitor)
|
Experiment 1 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Chronic myeloid leukemia [ICD-11:2A20] | ||||
| Human chronic myeloid leukemia cell lysate (K562) | ||||
| Interaction Atlas ID |
|
|||



